Gujarat Fluorochemicals Ltd Q1 FY27 Earnings Call: R-32 Capacity Doubling, EBITDA Margin Expands to 29%

Gujarat Fluorochemicals Ltd held its Q1 FY27 earnings call on August 12, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Strong Revenue Growth, Margin Expansion & Working Capital Improvement

• Chemical segment revenue Rs.1,574 Cr in Q1 FY27 — up 23% YoY from Rs.1,281 Cr in Q1 FY26; consolidated revenue Rs.1,588 Cr (+24% YoY)
• Chemical segment EBITDA Rs.458 Cr — up 29% YoY (Rs.354 Cr in Q1 FY26); EBITDA margin improved to 29% in Q1 FY27 from 26% in Q4 FY26
• Consolidated PAT Rs.219 Cr — up 19% YoY; PAT margin more than doubled QoQ from 7% to 14%
• ROCE improved 258 bps to 16.6% in Q1 FY27 (vs. 14.0% in FY26); ROE improved 301 bps to 15.18% (vs. 12.17% in FY26)
• Working capital reduced 43 days to 149 days as of Q1 FY27 (vs. 192 days as of Q4 FY26)
• Management noted that Q1 FY27 financial performance is not meeting internal expectations, though specific numbers were not disclosed (Segment 8)

Value Migration to High-Grade Products, Market Share Gains from 3M & AGC

• Fluoropolymer revenue grew ~15% YoY in Q1 FY27 — driven by demand from semiconductors, data centers, electronics, automotive, and green hydrogen
• Management expects 15-20% annual fluoropolymer growth in FY27, driven by product mix shift to higher-value grades and volume ramp-up from new capacity
• Most high-end fluoropolymer approvals expected to be in place by end of FY27, supporting commercial volume ramp-up in H2 FY27
• 3M exit fully absorbed — management stated the "impact of 3M's exit from the Fluoro Polymers market has been fully absorbed over the last two years"; GFL is now entering the high-end market vacated by 3M (Segment 13)
• AGC UK facility shutdown — management noted "AGC's announcement to shut down its UK facility" has generated inquiries; GFL has started the qualification process and expects traction in a quarter or two (Segment 13)
• Formula-based pricing protected margins in Q1 FY27 despite a 3-4x increase in sulfur prices and higher fluorspar costs — cost increases managed through customer understandings
• Price increases were taken to reflect input cost volatility, but growth is primarily from product mix shift and customer approvals, not pure pricing (Segment 12)

R-32 Capacity Doubling, R-134a Brownfield Entry & Quota Dynamics

• R-32 capacity of 10,000 tons nearly fully utilized in Q1 FY27; management expects full utilization of the expanded 20,000 tons during calendar year 2027 (Segment 13)
• R-32 capacity expansion to be commissioned in Q2 FY27; R-134a brownfield project at existing refrigerants site targeted for completion by end of FY27
• R-134a entry enables full HFC entitlement utilization across R32, 134a, 22, and 125 — rationale cited as "restricted future supply and robust demand as alternatives (HFOs) are at a very high price point" (Segment 3)
• Sales mix: 40-50% long-term contracts, remainder on spot or contract-to-contract basis (Segment 9)
• Regulator holds R-32 quota authority for new players under HFC phase-down — management stated "the decision rests with the regulator, not the company"; GFL's expansion is based on entitlement derived from its GWP number (Segment 4)
• Management was unclear on the distinction between production quota and consumption quota; will follow up with the analyst (Segment 9)
• AHF backward integration underway — first captive AHF capacity expected to be live by Q3 FY27, matched with refrigerant capacity additions (Segment 4)

Oman Project On Hold, India-First Strategy with Rs.4,000 Cr Investment

• Oman battery materials project (~$216 million) put on hold due to geopolitical delays; capacities being relocated to India to meet customer commitments — funding of ~Rs.1,200 Cr from OIA is also on hold and will not be available for the India project (Segment 6)
• Rs.4,000 Cr battery chemicals investment at Dahej with all approvals in place; an additional Dahej-area site being added for expansions toward end of FY27 and into FY28 (Segment 7)
• On track for 3-digit revenue from battery chemicals by Q4 FY27; significant ramp-up expected in FY28 (Segment 13)
• LiPF6 qualification nearly complete — entering growth phase; LFP and PVDF near finalization; cathode active material revenue expected toward end of FY27 (Segment 2)
• Management cited "domestic battery market potential of 220-250 GWh by 2030" as a key demand driver for the company's growth in FY28 and FY29 (Segment 2)
• Separate fund-raising process is ongoing for the India project; funds raised specifically for Oman will not be redeployed — management sees no constraint on execution (Segment 7)

Rs.6,000 Cr Capex Program, CWIP Capitalization & Growth Trajectory

• Total announced CAPEX: Rs.6,000 Cr over the next two years; FY27 spending: Rs.2,300 Cr in the EV business and ~Rs.800 Cr in the chemical business, which will add to CWIP before being capitalized later (Segment 5)
• ~Rs.1,200 Cr of Rs.1,900 Cr CWIP expected to be capitalized by end of FY27 — timing depends on plant mechanical completion and quality stabilization (Segment 5)
• Management stated "capex incurred over the past couple of years has started contributing to financials meaningfully in Q1 FY27" (Segment 14)
• Fluoropolymers expected to grow 17-20% annually going forward, driven by volume and high-value products — period unspecified but referenced as going forward from Q1 FY27 (Segment 14)
• Advanced Back-to-Material segment — after a rigorous qualification process, will now start contributing to financials and growth, with "sticky growth expected over the next few years" driven by demand explosion and global positioning (Segment 14)
• Demand drivers cited: semiconductor expansion in India, green hydrogen pilot projects moving to commercial scale, and data center approvals driving fluoropolymer traction (Segment 6)